nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—Nucleic Acid Synthesis Inhibitors—Azathioprine—multiple sclerosis	0.796	1	CiPCiCtD
Capecitabine—TYMS—Methotrexate—multiple sclerosis	0.0614	0.91	CbGbCtD
Capecitabine—CYP2C9—Dexamethasone—multiple sclerosis	0.00605	0.0897	CbGbCtD
Capecitabine—CES1—Phase I biotransformations, non P450—PON1—multiple sclerosis	0.00358	0.177	CbGpPWpGaD
Capecitabine—DPYD—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.00182	0.0897	CbGpPWpGaD
Capecitabine—CDA—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.00162	0.0799	CbGpPWpGaD
Capecitabine—TYMP—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.00129	0.0639	CbGpPWpGaD
Capecitabine—CES1—Irinotecan Pathway—BCHE—multiple sclerosis	0.00109	0.0537	CbGpPWpGaD
Capecitabine—CES1—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000954	0.0471	CbGpPWpGaD
Capecitabine—DPYD—Nucleotide metabolism—RRM1—multiple sclerosis	0.000913	0.0451	CbGpPWpGaD
Capecitabine—CDA—Nucleotide metabolism—RRM1—multiple sclerosis	0.000814	0.0402	CbGpPWpGaD
Capecitabine—TYMS—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000662	0.0327	CbGpPWpGaD
Capecitabine—TYMP—Nucleotide metabolism—RRM1—multiple sclerosis	0.000651	0.0321	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—RRM1—multiple sclerosis	0.000506	0.025	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—RRM1—multiple sclerosis	0.000351	0.0173	CbGpPWpGaD
Capecitabine—TYMS—Nucleotide metabolism—RRM1—multiple sclerosis	0.000333	0.0164	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—RRM1—multiple sclerosis	0.000305	0.015	CbGpPWpGaD
Capecitabine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000246	0.0121	CbGpPWpGaD
Capecitabine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000246	0.0121	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—MYC—multiple sclerosis	0.000234	0.0115	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—MAPK1—multiple sclerosis	0.000228	0.0113	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000163	0.00802	CbGpPWpGaD
Capecitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000156	0.0077	CbGpPWpGaD
Capecitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000156	0.0077	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—SRM—multiple sclerosis	0.000155	0.00766	CbGpPWpGaD
Capecitabine—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000154	0.0076	CbGpPWpGaD
Capecitabine—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000154	0.0076	CbGpPWpGaD
Capecitabine—CDA—Metabolism—SRM—multiple sclerosis	0.000138	0.00683	CbGpPWpGaD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000127	0.00625	CbGpPWpGaD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000127	0.00625	CbGpPWpGaD
Capecitabine—TYMS—Azacitidine—Cladribine—multiple sclerosis	0.000116	0.0491	CbGdCrCtD
Capecitabine—TYMP—Metabolism—SRM—multiple sclerosis	0.000111	0.00546	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CYP24A1—multiple sclerosis	0.000109	0.0054	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CYP27B1—multiple sclerosis	0.000109	0.0054	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GPC5—multiple sclerosis	0.0001	0.00494	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CYP27B1—multiple sclerosis	9.75e-05	0.00481	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CYP24A1—multiple sclerosis	9.75e-05	0.00481	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GPC5—multiple sclerosis	8.92e-05	0.0044	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	8.91e-05	0.0044	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—MYC—multiple sclerosis	8.68e-05	0.00428	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—RRM1—multiple sclerosis	8.29e-05	0.00409	CbGpPWpGaD
Capecitabine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	8.05e-05	0.00397	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CYP27B1—multiple sclerosis	7.8e-05	0.00385	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CYP24A1—multiple sclerosis	7.8e-05	0.00385	CbGpPWpGaD
Capecitabine—TYMS—Clobetasol propionate—Methylprednisolone—multiple sclerosis	7.46e-05	0.0315	CbGdCrCtD
Capecitabine—CDA—Metabolism—RRM1—multiple sclerosis	7.39e-05	0.00365	CbGpPWpGaD
Capecitabine—TYMS—Flunisolide—Methylprednisolone—multiple sclerosis	7.37e-05	0.0311	CbGdCrCtD
Capecitabine—TYMS—Clobetasol propionate—Dexamethasone—multiple sclerosis	7.35e-05	0.031	CbGdCrCtD
Capecitabine—TYMS—Clobetasol propionate—Betamethasone—multiple sclerosis	7.35e-05	0.031	CbGdCrCtD
Capecitabine—TYMS—Triamcinolone—Methylprednisolone—multiple sclerosis	7.29e-05	0.0308	CbGdCrCtD
Capecitabine—TYMS—Flunisolide—Betamethasone—multiple sclerosis	7.25e-05	0.0306	CbGdCrCtD
Capecitabine—TYMS—Flunisolide—Dexamethasone—multiple sclerosis	7.25e-05	0.0306	CbGdCrCtD
Capecitabine—TYMS—Clobetasol propionate—Triamcinolone—multiple sclerosis	7.18e-05	0.0303	CbGdCrCtD
Capecitabine—TYMS—Triamcinolone—Betamethasone—multiple sclerosis	7.18e-05	0.0303	CbGdCrCtD
Capecitabine—TYMS—Triamcinolone—Dexamethasone—multiple sclerosis	7.18e-05	0.0303	CbGdCrCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	7.15e-05	0.00353	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GPC5—multiple sclerosis	7.13e-05	0.00352	CbGpPWpGaD
Capecitabine—TYMS—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	7.11e-05	0.03	CbGdCrCtD
Capecitabine—TYMS—Flunisolide—Triamcinolone—multiple sclerosis	7.08e-05	0.0299	CbGdCrCtD
Capecitabine—TYMS—Fluticasone Propionate—Betamethasone—multiple sclerosis	7e-05	0.0295	CbGdCrCtD
Capecitabine—TYMS—Fluticasone Propionate—Dexamethasone—multiple sclerosis	7e-05	0.0295	CbGdCrCtD
Capecitabine—TYMS—Fluticasone Propionate—Triamcinolone—multiple sclerosis	6.84e-05	0.0289	CbGdCrCtD
Capecitabine—TYMS—Clobetasol propionate—Prednisone—multiple sclerosis	6.81e-05	0.0288	CbGdCrCtD
Capecitabine—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	6.72e-05	0.00332	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	6.72e-05	0.00332	CbGpPWpGaD
Capecitabine—TYMS—Flunisolide—Prednisone—multiple sclerosis	6.72e-05	0.0284	CbGdCrCtD
Capecitabine—TYMS—Diflorasone—Methylprednisolone—multiple sclerosis	6.72e-05	0.0284	CbGdCrCtD
Capecitabine—TYMS—Triamcinolone—Prednisone—multiple sclerosis	6.65e-05	0.0281	CbGdCrCtD
Capecitabine—TYMS—Clobetasol propionate—Prednisolone—multiple sclerosis	6.65e-05	0.0281	CbGdCrCtD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	6.63e-05	0.00327	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	6.63e-05	0.00327	CbGpPWpGaD
Capecitabine—TYMS—Diflorasone—Betamethasone—multiple sclerosis	6.61e-05	0.0279	CbGdCrCtD
Capecitabine—TYMS—Diflorasone—Dexamethasone—multiple sclerosis	6.61e-05	0.0279	CbGdCrCtD
Capecitabine—TYMS—Flunisolide—Prednisolone—multiple sclerosis	6.56e-05	0.0277	CbGdCrCtD
Capecitabine—TYMS—Triamcinolone—Prednisolone—multiple sclerosis	6.5e-05	0.0274	CbGdCrCtD
Capecitabine—TYMS—Diflorasone—Triamcinolone—multiple sclerosis	6.46e-05	0.0273	CbGdCrCtD
Capecitabine—TYMS—Diflorasone—Prednisone—multiple sclerosis	6.13e-05	0.0259	CbGdCrCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	6.12e-05	0.00302	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—MYC—multiple sclerosis	6.02e-05	0.00297	CbGpPWpGaD
Capecitabine—TYMS—Diflorasone—Prednisolone—multiple sclerosis	5.99e-05	0.0253	CbGdCrCtD
Capecitabine—TYMP—Metabolism—RRM1—multiple sclerosis	5.91e-05	0.00292	CbGpPWpGaD
Capecitabine—TYMS—Budesonide—Methylprednisolone—multiple sclerosis	5.89e-05	0.0249	CbGdCrCtD
Capecitabine—TYMS—Circadian rythm related genes—FAS—multiple sclerosis	5.88e-05	0.0029	CbGpPWpGaD
Capecitabine—TYMS—Budesonide—Betamethasone—multiple sclerosis	5.8e-05	0.0245	CbGdCrCtD
Capecitabine—TYMS—Budesonide—Dexamethasone—multiple sclerosis	5.8e-05	0.0245	CbGdCrCtD
Capecitabine—TYMS—Budesonide—Triamcinolone—multiple sclerosis	5.67e-05	0.0239	CbGdCrCtD
Capecitabine—TYMS—Metabolism—SRM—multiple sclerosis	5.66e-05	0.00279	CbGpPWpGaD
Capecitabine—TYMS—Budesonide—Prednisone—multiple sclerosis	5.38e-05	0.0227	CbGdCrCtD
Capecitabine—TYMS—Budesonide—Prednisolone—multiple sclerosis	5.25e-05	0.0222	CbGdCrCtD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	5.23e-05	0.00258	CbGpPWpGaD
Capecitabine—TYMS—Danazol—Prednisone—multiple sclerosis	5.15e-05	0.0218	CbGdCrCtD
Capecitabine—CES1—NRF2 pathway—TGFB1—multiple sclerosis	4.97e-05	0.00245	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—BCHE—multiple sclerosis	4.76e-05	0.00235	CbGpPWpGaD
Capecitabine—TYMS—G1/S Transition—MYC—multiple sclerosis	4.37e-05	0.00216	CbGpPWpGaD
Capecitabine—CDA—Metabolism—BCHE—multiple sclerosis	4.25e-05	0.0021	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP27B1—multiple sclerosis	3.99e-05	0.00197	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP24A1—multiple sclerosis	3.99e-05	0.00197	CbGpPWpGaD
Capecitabine—Hepatobiliary disease—Methotrexate—multiple sclerosis	3.89e-05	0.00034	CcSEcCtD
Capecitabine—Nervous system disorder—Methylprednisolone—multiple sclerosis	3.89e-05	0.00034	CcSEcCtD
Capecitabine—Loss of consciousness—Dexamethasone—multiple sclerosis	3.88e-05	0.00034	CcSEcCtD
Capecitabine—Loss of consciousness—Betamethasone—multiple sclerosis	3.88e-05	0.00034	CcSEcCtD
Capecitabine—Epistaxis—Methotrexate—multiple sclerosis	3.88e-05	0.000339	CcSEcCtD
Capecitabine—Hypersensitivity—Mitoxantrone—multiple sclerosis	3.88e-05	0.000339	CcSEcCtD
Capecitabine—Paraesthesia—Prednisolone—multiple sclerosis	3.88e-05	0.000339	CcSEcCtD
Capecitabine—Tachycardia—Triamcinolone—multiple sclerosis	3.88e-05	0.000339	CcSEcCtD
Capecitabine—Mental disorder—Prednisone—multiple sclerosis	3.87e-05	0.000339	CcSEcCtD
Capecitabine—Nausea—Azathioprine—multiple sclerosis	3.87e-05	0.000338	CcSEcCtD
Capecitabine—Tachycardia—Methylprednisolone—multiple sclerosis	3.87e-05	0.000338	CcSEcCtD
Capecitabine—Skin disorder—Methylprednisolone—multiple sclerosis	3.85e-05	0.000337	CcSEcCtD
Capecitabine—Malnutrition—Prednisone—multiple sclerosis	3.85e-05	0.000337	CcSEcCtD
Capecitabine—Erythema—Prednisone—multiple sclerosis	3.85e-05	0.000337	CcSEcCtD
Capecitabine—Hyperhidrosis—Triamcinolone—multiple sclerosis	3.84e-05	0.000336	CcSEcCtD
Capecitabine—Agranulocytosis—Methotrexate—multiple sclerosis	3.84e-05	0.000336	CcSEcCtD
Capecitabine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	3.83e-05	0.000335	CcSEcCtD
Capecitabine—Hypertension—Dexamethasone—multiple sclerosis	3.81e-05	0.000334	CcSEcCtD
Capecitabine—Hypertension—Betamethasone—multiple sclerosis	3.81e-05	0.000334	CcSEcCtD
Capecitabine—Asthenia—Mitoxantrone—multiple sclerosis	3.78e-05	0.000331	CcSEcCtD
Capecitabine—Myalgia—Betamethasone—multiple sclerosis	3.76e-05	0.000329	CcSEcCtD
Capecitabine—Myalgia—Dexamethasone—multiple sclerosis	3.76e-05	0.000329	CcSEcCtD
Capecitabine—Anxiety—Dexamethasone—multiple sclerosis	3.75e-05	0.000328	CcSEcCtD
Capecitabine—Anxiety—Betamethasone—multiple sclerosis	3.75e-05	0.000328	CcSEcCtD
Capecitabine—Discomfort—Dexamethasone—multiple sclerosis	3.72e-05	0.000325	CcSEcCtD
Capecitabine—Discomfort—Betamethasone—multiple sclerosis	3.72e-05	0.000325	CcSEcCtD
Capecitabine—Haemoglobin—Methotrexate—multiple sclerosis	3.71e-05	0.000325	CcSEcCtD
Capecitabine—Hypotension—Methylprednisolone—multiple sclerosis	3.71e-05	0.000324	CcSEcCtD
Capecitabine—Pain—Prednisolone—multiple sclerosis	3.7e-05	0.000323	CcSEcCtD
Capecitabine—Hepatitis—Methotrexate—multiple sclerosis	3.69e-05	0.000323	CcSEcCtD
Capecitabine—Haemorrhage—Methotrexate—multiple sclerosis	3.69e-05	0.000323	CcSEcCtD
Capecitabine—TYMS—Mitotic G1-G1/S phases—MYC—multiple sclerosis	3.68e-05	0.00182	CbGpPWpGaD
Capecitabine—Pharyngitis—Methotrexate—multiple sclerosis	3.67e-05	0.000321	CcSEcCtD
Capecitabine—TYMS—Metabolism—GPC5—multiple sclerosis	3.65e-05	0.0018	CbGpPWpGaD
Capecitabine—Urinary tract disorder—Methotrexate—multiple sclerosis	3.65e-05	0.000319	CcSEcCtD
Capecitabine—Vision blurred—Prednisone—multiple sclerosis	3.63e-05	0.000317	CcSEcCtD
Capecitabine—Urethral disorder—Methotrexate—multiple sclerosis	3.62e-05	0.000317	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	3.62e-05	0.000317	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	3.61e-05	0.000316	CcSEcCtD
Capecitabine—Oedema—Dexamethasone—multiple sclerosis	3.61e-05	0.000315	CcSEcCtD
Capecitabine—Oedema—Betamethasone—multiple sclerosis	3.61e-05	0.000315	CcSEcCtD
Capecitabine—Diarrhoea—Mitoxantrone—multiple sclerosis	3.6e-05	0.000315	CcSEcCtD
Capecitabine—Insomnia—Triamcinolone—multiple sclerosis	3.59e-05	0.000314	CcSEcCtD
Capecitabine—Insomnia—Methylprednisolone—multiple sclerosis	3.59e-05	0.000314	CcSEcCtD
Capecitabine—Infection—Betamethasone—multiple sclerosis	3.58e-05	0.000313	CcSEcCtD
Capecitabine—Infection—Dexamethasone—multiple sclerosis	3.58e-05	0.000313	CcSEcCtD
Capecitabine—Ill-defined disorder—Prednisone—multiple sclerosis	3.57e-05	0.000312	CcSEcCtD
Capecitabine—Paraesthesia—Triamcinolone—multiple sclerosis	3.57e-05	0.000312	CcSEcCtD
Capecitabine—Feeling abnormal—Prednisolone—multiple sclerosis	3.56e-05	0.000311	CcSEcCtD
Capecitabine—Paraesthesia—Methylprednisolone—multiple sclerosis	3.56e-05	0.000311	CcSEcCtD
Capecitabine—Visual impairment—Methotrexate—multiple sclerosis	3.56e-05	0.000311	CcSEcCtD
Capecitabine—Anaemia—Prednisone—multiple sclerosis	3.56e-05	0.000311	CcSEcCtD
Capecitabine—Shock—Dexamethasone—multiple sclerosis	3.55e-05	0.00031	CcSEcCtD
Capecitabine—Shock—Betamethasone—multiple sclerosis	3.55e-05	0.00031	CcSEcCtD
Capecitabine—Dyspnoea—Triamcinolone—multiple sclerosis	3.54e-05	0.00031	CcSEcCtD
Capecitabine—Nervous system disorder—Dexamethasone—multiple sclerosis	3.54e-05	0.000309	CcSEcCtD
Capecitabine—Nervous system disorder—Betamethasone—multiple sclerosis	3.54e-05	0.000309	CcSEcCtD
Capecitabine—Thrombocytopenia—Dexamethasone—multiple sclerosis	3.53e-05	0.000309	CcSEcCtD
Capecitabine—Thrombocytopenia—Betamethasone—multiple sclerosis	3.53e-05	0.000309	CcSEcCtD
Capecitabine—Tachycardia—Betamethasone—multiple sclerosis	3.52e-05	0.000308	CcSEcCtD
Capecitabine—Tachycardia—Dexamethasone—multiple sclerosis	3.52e-05	0.000308	CcSEcCtD
Capecitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.51e-05	0.00173	CbGpPWpGaD
Capecitabine—Dyspepsia—Triamcinolone—multiple sclerosis	3.5e-05	0.000306	CcSEcCtD
Capecitabine—Erythema multiforme—Methotrexate—multiple sclerosis	3.49e-05	0.000305	CcSEcCtD
Capecitabine—Dyspepsia—Methylprednisolone—multiple sclerosis	3.49e-05	0.000305	CcSEcCtD
Capecitabine—Hyperhidrosis—Betamethasone—multiple sclerosis	3.49e-05	0.000305	CcSEcCtD
Capecitabine—Hyperhidrosis—Dexamethasone—multiple sclerosis	3.49e-05	0.000305	CcSEcCtD
Capecitabine—Malaise—Prednisone—multiple sclerosis	3.47e-05	0.000303	CcSEcCtD
Capecitabine—Vertigo—Prednisone—multiple sclerosis	3.46e-05	0.000302	CcSEcCtD
Capecitabine—Eye disorder—Methotrexate—multiple sclerosis	3.45e-05	0.000302	CcSEcCtD
Capecitabine—Syncope—Prednisone—multiple sclerosis	3.45e-05	0.000302	CcSEcCtD
Capecitabine—Tinnitus—Methotrexate—multiple sclerosis	3.44e-05	0.000301	CcSEcCtD
Capecitabine—Anorexia—Dexamethasone—multiple sclerosis	3.44e-05	0.000301	CcSEcCtD
Capecitabine—Anorexia—Betamethasone—multiple sclerosis	3.44e-05	0.000301	CcSEcCtD
Capecitabine—Urticaria—Prednisolone—multiple sclerosis	3.43e-05	0.0003	CcSEcCtD
Capecitabine—Cardiac disorder—Methotrexate—multiple sclerosis	3.43e-05	0.0003	CcSEcCtD
Capecitabine—Fatigue—Triamcinolone—multiple sclerosis	3.43e-05	0.0003	CcSEcCtD
Capecitabine—Fatigue—Methylprednisolone—multiple sclerosis	3.42e-05	0.000299	CcSEcCtD
Capecitabine—Pain—Triamcinolone—multiple sclerosis	3.4e-05	0.000297	CcSEcCtD
Capecitabine—TYMP—Metabolism—BCHE—multiple sclerosis	3.39e-05	0.00167	CbGpPWpGaD
Capecitabine—Loss of consciousness—Prednisone—multiple sclerosis	3.38e-05	0.000296	CcSEcCtD
Capecitabine—Hypotension—Betamethasone—multiple sclerosis	3.37e-05	0.000295	CcSEcCtD
Capecitabine—Hypotension—Dexamethasone—multiple sclerosis	3.37e-05	0.000295	CcSEcCtD
Capecitabine—Angiopathy—Methotrexate—multiple sclerosis	3.35e-05	0.000293	CcSEcCtD
Capecitabine—Vomiting—Mitoxantrone—multiple sclerosis	3.35e-05	0.000293	CcSEcCtD
Capecitabine—Immune system disorder—Methotrexate—multiple sclerosis	3.34e-05	0.000292	CcSEcCtD
Capecitabine—Mediastinal disorder—Methotrexate—multiple sclerosis	3.33e-05	0.000291	CcSEcCtD
Capecitabine—Hypertension—Prednisone—multiple sclerosis	3.32e-05	0.000291	CcSEcCtD
Capecitabine—Rash—Mitoxantrone—multiple sclerosis	3.32e-05	0.00029	CcSEcCtD
Capecitabine—Dermatitis—Mitoxantrone—multiple sclerosis	3.32e-05	0.00029	CcSEcCtD
Capecitabine—Chills—Methotrexate—multiple sclerosis	3.31e-05	0.00029	CcSEcCtD
Capecitabine—Headache—Mitoxantrone—multiple sclerosis	3.3e-05	0.000289	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	3.29e-05	0.000287	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	3.29e-05	0.000287	CcSEcCtD
Capecitabine—Myalgia—Prednisone—multiple sclerosis	3.28e-05	0.000286	CcSEcCtD
Capecitabine—Arthralgia—Prednisone—multiple sclerosis	3.28e-05	0.000286	CcSEcCtD
Capecitabine—Feeling abnormal—Triamcinolone—multiple sclerosis	3.27e-05	0.000286	CcSEcCtD
Capecitabine—Feeling abnormal—Methylprednisolone—multiple sclerosis	3.27e-05	0.000286	CcSEcCtD
Capecitabine—Anxiety—Prednisone—multiple sclerosis	3.26e-05	0.000285	CcSEcCtD
Capecitabine—Alopecia—Methotrexate—multiple sclerosis	3.26e-05	0.000285	CcSEcCtD
Capecitabine—Insomnia—Dexamethasone—multiple sclerosis	3.26e-05	0.000285	CcSEcCtD
Capecitabine—Insomnia—Betamethasone—multiple sclerosis	3.26e-05	0.000285	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	3.25e-05	0.000285	CcSEcCtD
Capecitabine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	3.24e-05	0.000284	CcSEcCtD
Capecitabine—Paraesthesia—Betamethasone—multiple sclerosis	3.24e-05	0.000283	CcSEcCtD
Capecitabine—Paraesthesia—Dexamethasone—multiple sclerosis	3.24e-05	0.000283	CcSEcCtD
Capecitabine—Discomfort—Prednisone—multiple sclerosis	3.24e-05	0.000283	CcSEcCtD
Capecitabine—Mental disorder—Methotrexate—multiple sclerosis	3.24e-05	0.000283	CcSEcCtD
Capecitabine—Erythema—Methotrexate—multiple sclerosis	3.22e-05	0.000281	CcSEcCtD
Capecitabine—Malnutrition—Methotrexate—multiple sclerosis	3.22e-05	0.000281	CcSEcCtD
Capecitabine—Hypersensitivity—Prednisolone—multiple sclerosis	3.18e-05	0.000278	CcSEcCtD
Capecitabine—Dyspepsia—Betamethasone—multiple sclerosis	3.17e-05	0.000278	CcSEcCtD
Capecitabine—Dyspepsia—Dexamethasone—multiple sclerosis	3.17e-05	0.000278	CcSEcCtD
Capecitabine—Urticaria—Triamcinolone—multiple sclerosis	3.16e-05	0.000276	CcSEcCtD
Capecitabine—Urticaria—Methylprednisolone—multiple sclerosis	3.15e-05	0.000275	CcSEcCtD
Capecitabine—Dysgeusia—Methotrexate—multiple sclerosis	3.15e-05	0.000275	CcSEcCtD
Capecitabine—Body temperature increased—Triamcinolone—multiple sclerosis	3.14e-05	0.000275	CcSEcCtD
Capecitabine—Oedema—Prednisone—multiple sclerosis	3.14e-05	0.000275	CcSEcCtD
Capecitabine—Abdominal pain—Methylprednisolone—multiple sclerosis	3.13e-05	0.000274	CcSEcCtD
Capecitabine—Decreased appetite—Dexamethasone—multiple sclerosis	3.13e-05	0.000274	CcSEcCtD
Capecitabine—Decreased appetite—Betamethasone—multiple sclerosis	3.13e-05	0.000274	CcSEcCtD
Capecitabine—Nausea—Mitoxantrone—multiple sclerosis	3.13e-05	0.000274	CcSEcCtD
Capecitabine—Infection—Prednisone—multiple sclerosis	3.12e-05	0.000273	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	3.11e-05	0.000272	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	3.11e-05	0.000272	CcSEcCtD
Capecitabine—Back pain—Methotrexate—multiple sclerosis	3.11e-05	0.000272	CcSEcCtD
Capecitabine—Fatigue—Dexamethasone—multiple sclerosis	3.11e-05	0.000272	CcSEcCtD
Capecitabine—Fatigue—Betamethasone—multiple sclerosis	3.11e-05	0.000272	CcSEcCtD
Capecitabine—Shock—Prednisone—multiple sclerosis	3.09e-05	0.00027	CcSEcCtD
Capecitabine—Pain—Dexamethasone—multiple sclerosis	3.08e-05	0.00027	CcSEcCtD
Capecitabine—Pain—Betamethasone—multiple sclerosis	3.08e-05	0.00027	CcSEcCtD
Capecitabine—Nervous system disorder—Prednisone—multiple sclerosis	3.08e-05	0.000269	CcSEcCtD
Capecitabine—Tachycardia—Prednisone—multiple sclerosis	3.06e-05	0.000268	CcSEcCtD
Capecitabine—Skin disorder—Prednisone—multiple sclerosis	3.05e-05	0.000267	CcSEcCtD
Capecitabine—Hyperhidrosis—Prednisone—multiple sclerosis	3.04e-05	0.000265	CcSEcCtD
Capecitabine—Vision blurred—Methotrexate—multiple sclerosis	3.03e-05	0.000265	CcSEcCtD
Capecitabine—TYMS—Metabolism—RRM1—multiple sclerosis	3.02e-05	0.00149	CbGpPWpGaD
Capecitabine—Anorexia—Prednisone—multiple sclerosis	2.99e-05	0.000262	CcSEcCtD
Capecitabine—Ill-defined disorder—Methotrexate—multiple sclerosis	2.98e-05	0.000261	CcSEcCtD
Capecitabine—Anaemia—Methotrexate—multiple sclerosis	2.97e-05	0.00026	CcSEcCtD
Capecitabine—Feeling abnormal—Betamethasone—multiple sclerosis	2.97e-05	0.00026	CcSEcCtD
Capecitabine—Feeling abnormal—Dexamethasone—multiple sclerosis	2.97e-05	0.00026	CcSEcCtD
Capecitabine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	2.95e-05	0.000258	CcSEcCtD
Capecitabine—Gastrointestinal pain—Betamethasone—multiple sclerosis	2.95e-05	0.000258	CcSEcCtD
Capecitabine—Hypersensitivity—Triamcinolone—multiple sclerosis	2.93e-05	0.000256	CcSEcCtD
Capecitabine—Hypersensitivity—Methylprednisolone—multiple sclerosis	2.92e-05	0.000255	CcSEcCtD
Capecitabine—Malaise—Methotrexate—multiple sclerosis	2.9e-05	0.000254	CcSEcCtD
Capecitabine—Vertigo—Methotrexate—multiple sclerosis	2.89e-05	0.000253	CcSEcCtD
Capecitabine—Leukopenia—Methotrexate—multiple sclerosis	2.88e-05	0.000252	CcSEcCtD
Capecitabine—DPYD—Metabolism—APOE—multiple sclerosis	2.87e-05	0.00141	CbGpPWpGaD
Capecitabine—Urticaria—Dexamethasone—multiple sclerosis	2.86e-05	0.000251	CcSEcCtD
Capecitabine—Urticaria—Betamethasone—multiple sclerosis	2.86e-05	0.000251	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	2.86e-05	0.00025	CcSEcCtD
Capecitabine—Dizziness—Prednisolone—multiple sclerosis	2.86e-05	0.00025	CcSEcCtD
Capecitabine—Asthenia—Triamcinolone—multiple sclerosis	2.85e-05	0.000249	CcSEcCtD
Capecitabine—Body temperature increased—Betamethasone—multiple sclerosis	2.85e-05	0.000249	CcSEcCtD
Capecitabine—Body temperature increased—Dexamethasone—multiple sclerosis	2.85e-05	0.000249	CcSEcCtD
Capecitabine—Abdominal pain—Betamethasone—multiple sclerosis	2.85e-05	0.000249	CcSEcCtD
Capecitabine—Abdominal pain—Dexamethasone—multiple sclerosis	2.85e-05	0.000249	CcSEcCtD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.85e-05	0.00141	CbGpPWpGaD
Capecitabine—Asthenia—Methylprednisolone—multiple sclerosis	2.84e-05	0.000249	CcSEcCtD
Capecitabine—Insomnia—Prednisone—multiple sclerosis	2.84e-05	0.000248	CcSEcCtD
Capecitabine—Paraesthesia—Prednisone—multiple sclerosis	2.82e-05	0.000247	CcSEcCtD
Capecitabine—Pruritus—Triamcinolone—multiple sclerosis	2.81e-05	0.000246	CcSEcCtD
Capecitabine—Cough—Methotrexate—multiple sclerosis	2.81e-05	0.000245	CcSEcCtD
Capecitabine—Pruritus—Methylprednisolone—multiple sclerosis	2.81e-05	0.000245	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.79e-05	0.00138	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.78e-05	0.00137	CbGpPWpGaD
Capecitabine—Dyspepsia—Prednisone—multiple sclerosis	2.76e-05	0.000242	CcSEcCtD
Capecitabine—Chest pain—Methotrexate—multiple sclerosis	2.74e-05	0.000239	CcSEcCtD
Capecitabine—Myalgia—Methotrexate—multiple sclerosis	2.74e-05	0.000239	CcSEcCtD
Capecitabine—Arthralgia—Methotrexate—multiple sclerosis	2.74e-05	0.000239	CcSEcCtD
Capecitabine—Decreased appetite—Prednisone—multiple sclerosis	2.73e-05	0.000239	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.73e-05	0.00135	CbGpPWpGaD
Capecitabine—Rash—Prednisolone—multiple sclerosis	2.72e-05	0.000238	CcSEcCtD
Capecitabine—Dermatitis—Prednisolone—multiple sclerosis	2.72e-05	0.000238	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	2.72e-05	0.000238	CcSEcCtD
Capecitabine—Diarrhoea—Methylprednisolone—multiple sclerosis	2.71e-05	0.000237	CcSEcCtD
Capecitabine—Fatigue—Prednisone—multiple sclerosis	2.71e-05	0.000237	CcSEcCtD
Capecitabine—Headache—Prednisolone—multiple sclerosis	2.71e-05	0.000237	CcSEcCtD
Capecitabine—Discomfort—Methotrexate—multiple sclerosis	2.7e-05	0.000237	CcSEcCtD
Capecitabine—Constipation—Prednisone—multiple sclerosis	2.69e-05	0.000235	CcSEcCtD
Capecitabine—Confusional state—Methotrexate—multiple sclerosis	2.65e-05	0.000231	CcSEcCtD
Capecitabine—Dizziness—Triamcinolone—multiple sclerosis	2.63e-05	0.00023	CcSEcCtD
Capecitabine—Dizziness—Methylprednisolone—multiple sclerosis	2.62e-05	0.000229	CcSEcCtD
Capecitabine—Infection—Methotrexate—multiple sclerosis	2.61e-05	0.000228	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.6e-05	0.00128	CbGpPWpGaD
Capecitabine—Feeling abnormal—Prednisone—multiple sclerosis	2.59e-05	0.000226	CcSEcCtD
Capecitabine—Asthenia—Dexamethasone—multiple sclerosis	2.59e-05	0.000226	CcSEcCtD
Capecitabine—Asthenia—Betamethasone—multiple sclerosis	2.59e-05	0.000226	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.58e-05	0.00127	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.58e-05	0.00127	CbGpPWpGaD
Capecitabine—Nervous system disorder—Methotrexate—multiple sclerosis	2.57e-05	0.000225	CcSEcCtD
Capecitabine—Thrombocytopenia—Methotrexate—multiple sclerosis	2.57e-05	0.000225	CcSEcCtD
Capecitabine—Gastrointestinal pain—Prednisone—multiple sclerosis	2.57e-05	0.000225	CcSEcCtD
Capecitabine—Nausea—Prednisolone—multiple sclerosis	2.57e-05	0.000224	CcSEcCtD
Capecitabine—CDA—Metabolism—APOE—multiple sclerosis	2.55e-05	0.00126	CbGpPWpGaD
Capecitabine—Pruritus—Betamethasone—multiple sclerosis	2.55e-05	0.000223	CcSEcCtD
Capecitabine—Pruritus—Dexamethasone—multiple sclerosis	2.55e-05	0.000223	CcSEcCtD
Capecitabine—Skin disorder—Methotrexate—multiple sclerosis	2.55e-05	0.000223	CcSEcCtD
Capecitabine—Hyperhidrosis—Methotrexate—multiple sclerosis	2.54e-05	0.000222	CcSEcCtD
Capecitabine—Vomiting—Triamcinolone—multiple sclerosis	2.53e-05	0.000221	CcSEcCtD
Capecitabine—Vomiting—Methylprednisolone—multiple sclerosis	2.52e-05	0.00022	CcSEcCtD
Capecitabine—Rash—Triamcinolone—multiple sclerosis	2.51e-05	0.000219	CcSEcCtD
Capecitabine—Dermatitis—Triamcinolone—multiple sclerosis	2.5e-05	0.000219	CcSEcCtD
Capecitabine—Anorexia—Methotrexate—multiple sclerosis	2.5e-05	0.000219	CcSEcCtD
Capecitabine—Rash—Methylprednisolone—multiple sclerosis	2.5e-05	0.000219	CcSEcCtD
Capecitabine—Dermatitis—Methylprednisolone—multiple sclerosis	2.5e-05	0.000218	CcSEcCtD
Capecitabine—Urticaria—Prednisone—multiple sclerosis	2.49e-05	0.000218	CcSEcCtD
Capecitabine—Headache—Triamcinolone—multiple sclerosis	2.49e-05	0.000218	CcSEcCtD
Capecitabine—Headache—Methylprednisolone—multiple sclerosis	2.48e-05	0.000217	CcSEcCtD
Capecitabine—Body temperature increased—Prednisone—multiple sclerosis	2.48e-05	0.000217	CcSEcCtD
Capecitabine—Abdominal pain—Prednisone—multiple sclerosis	2.48e-05	0.000217	CcSEcCtD
Capecitabine—Diarrhoea—Betamethasone—multiple sclerosis	2.47e-05	0.000216	CcSEcCtD
Capecitabine—Diarrhoea—Dexamethasone—multiple sclerosis	2.47e-05	0.000216	CcSEcCtD
Capecitabine—DPYD—Metabolism—POMC—multiple sclerosis	2.46e-05	0.00121	CbGpPWpGaD
Capecitabine—Hypotension—Methotrexate—multiple sclerosis	2.45e-05	0.000214	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	2.39e-05	0.000209	CcSEcCtD
Capecitabine—Dizziness—Betamethasone—multiple sclerosis	2.38e-05	0.000209	CcSEcCtD
Capecitabine—Dizziness—Dexamethasone—multiple sclerosis	2.38e-05	0.000209	CcSEcCtD
Capecitabine—Insomnia—Methotrexate—multiple sclerosis	2.37e-05	0.000208	CcSEcCtD
Capecitabine—Nausea—Triamcinolone—multiple sclerosis	2.36e-05	0.000206	CcSEcCtD
Capecitabine—Paraesthesia—Methotrexate—multiple sclerosis	2.36e-05	0.000206	CcSEcCtD
Capecitabine—Nausea—Methylprednisolone—multiple sclerosis	2.36e-05	0.000206	CcSEcCtD
Capecitabine—Dyspnoea—Methotrexate—multiple sclerosis	2.34e-05	0.000205	CcSEcCtD
Capecitabine—Hypersensitivity—Prednisone—multiple sclerosis	2.31e-05	0.000202	CcSEcCtD
Capecitabine—Dyspepsia—Methotrexate—multiple sclerosis	2.31e-05	0.000202	CcSEcCtD
Capecitabine—Vomiting—Dexamethasone—multiple sclerosis	2.29e-05	0.000201	CcSEcCtD
Capecitabine—Vomiting—Betamethasone—multiple sclerosis	2.29e-05	0.000201	CcSEcCtD
Capecitabine—Decreased appetite—Methotrexate—multiple sclerosis	2.28e-05	0.0002	CcSEcCtD
Capecitabine—Rash—Betamethasone—multiple sclerosis	2.27e-05	0.000199	CcSEcCtD
Capecitabine—Rash—Dexamethasone—multiple sclerosis	2.27e-05	0.000199	CcSEcCtD
Capecitabine—Dermatitis—Betamethasone—multiple sclerosis	2.27e-05	0.000199	CcSEcCtD
Capecitabine—Dermatitis—Dexamethasone—multiple sclerosis	2.27e-05	0.000199	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	2.27e-05	0.000198	CcSEcCtD
Capecitabine—Fatigue—Methotrexate—multiple sclerosis	2.26e-05	0.000198	CcSEcCtD
Capecitabine—Headache—Betamethasone—multiple sclerosis	2.26e-05	0.000198	CcSEcCtD
Capecitabine—Headache—Dexamethasone—multiple sclerosis	2.26e-05	0.000198	CcSEcCtD
Capecitabine—Asthenia—Prednisone—multiple sclerosis	2.25e-05	0.000197	CcSEcCtD
Capecitabine—DPYD—Metabolism—ALB—multiple sclerosis	2.24e-05	0.00111	CbGpPWpGaD
Capecitabine—Pain—Methotrexate—multiple sclerosis	2.24e-05	0.000196	CcSEcCtD
Capecitabine—Pruritus—Prednisone—multiple sclerosis	2.22e-05	0.000194	CcSEcCtD
Capecitabine—CDA—Metabolism—POMC—multiple sclerosis	2.19e-05	0.00108	CbGpPWpGaD
Capecitabine—Feeling abnormal—Methotrexate—multiple sclerosis	2.16e-05	0.000189	CcSEcCtD
Capecitabine—Diarrhoea—Prednisone—multiple sclerosis	2.15e-05	0.000188	CcSEcCtD
Capecitabine—Gastrointestinal pain—Methotrexate—multiple sclerosis	2.15e-05	0.000188	CcSEcCtD
Capecitabine—Nausea—Betamethasone—multiple sclerosis	2.14e-05	0.000187	CcSEcCtD
Capecitabine—Nausea—Dexamethasone—multiple sclerosis	2.14e-05	0.000187	CcSEcCtD
Capecitabine—Urticaria—Methotrexate—multiple sclerosis	2.08e-05	0.000182	CcSEcCtD
Capecitabine—Dizziness—Prednisone—multiple sclerosis	2.08e-05	0.000182	CcSEcCtD
Capecitabine—Body temperature increased—Methotrexate—multiple sclerosis	2.07e-05	0.000181	CcSEcCtD
Capecitabine—Abdominal pain—Methotrexate—multiple sclerosis	2.07e-05	0.000181	CcSEcCtD
Capecitabine—TYMP—Metabolism—APOE—multiple sclerosis	2.04e-05	0.00101	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—IL6—multiple sclerosis	2.01e-05	0.000993	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ALB—multiple sclerosis	2e-05	0.000987	CbGpPWpGaD
Capecitabine—Vomiting—Prednisone—multiple sclerosis	2e-05	0.000175	CcSEcCtD
Capecitabine—Rash—Prednisone—multiple sclerosis	1.98e-05	0.000173	CcSEcCtD
Capecitabine—Dermatitis—Prednisone—multiple sclerosis	1.98e-05	0.000173	CcSEcCtD
Capecitabine—Headache—Prednisone—multiple sclerosis	1.97e-05	0.000172	CcSEcCtD
Capecitabine—Hypersensitivity—Methotrexate—multiple sclerosis	1.93e-05	0.000169	CcSEcCtD
Capecitabine—Asthenia—Methotrexate—multiple sclerosis	1.88e-05	0.000165	CcSEcCtD
Capecitabine—Nausea—Prednisone—multiple sclerosis	1.87e-05	0.000163	CcSEcCtD
Capecitabine—Pruritus—Methotrexate—multiple sclerosis	1.86e-05	0.000162	CcSEcCtD
Capecitabine—Diarrhoea—Methotrexate—multiple sclerosis	1.8e-05	0.000157	CcSEcCtD
Capecitabine—TYMP—Metabolism—POMC—multiple sclerosis	1.75e-05	0.000866	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—BCHE—multiple sclerosis	1.74e-05	0.000857	CbGpPWpGaD
Capecitabine—Dizziness—Methotrexate—multiple sclerosis	1.74e-05	0.000152	CcSEcCtD
Capecitabine—Vomiting—Methotrexate—multiple sclerosis	1.67e-05	0.000146	CcSEcCtD
Capecitabine—Rash—Methotrexate—multiple sclerosis	1.65e-05	0.000145	CcSEcCtD
Capecitabine—Dermatitis—Methotrexate—multiple sclerosis	1.65e-05	0.000145	CcSEcCtD
Capecitabine—Headache—Methotrexate—multiple sclerosis	1.64e-05	0.000144	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—SRM—multiple sclerosis	1.63e-05	0.000805	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ALB—multiple sclerosis	1.6e-05	0.000789	CbGpPWpGaD
Capecitabine—Nausea—Methotrexate—multiple sclerosis	1.56e-05	0.000136	CcSEcCtD
Capecitabine—CYP2C9—Biological oxidations—POMC—multiple sclerosis	1.51e-05	0.000746	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—MYC—multiple sclerosis	1.35e-05	0.000666	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	1.32e-05	0.000652	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MYC—multiple sclerosis	1.21e-05	0.000596	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MAPK1—multiple sclerosis	1.18e-05	0.000583	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.15e-05	0.000567	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.15e-05	0.000567	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.12e-05	0.000555	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.05e-05	0.000519	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—APOE—multiple sclerosis	1.04e-05	0.000515	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—POMC—multiple sclerosis	8.97e-06	0.000443	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—RRM1—multiple sclerosis	8.71e-06	0.00043	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ALB—multiple sclerosis	8.18e-06	0.000404	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.76e-06	0.000334	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.81e-06	0.000287	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.3e-06	0.000261	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—BCHE—multiple sclerosis	5e-06	0.000247	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—APOE—multiple sclerosis	3.01e-06	0.000149	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—POMC—multiple sclerosis	2.59e-06	0.000128	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ALB—multiple sclerosis	2.36e-06	0.000116	CbGpPWpGaD
